Reset
Showing 20 of 83 academic articles

Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening

Ilana B. Richman, Taara V. Prasad, Cary P. Gross • Preventive Medicine Reports (2022)

Although national guidelines recommend lung cancer screening for adults at high risk, only a small proportion of eligible adults in the US have been screened. The goal of this study was to understand barriers to screening among a specific b...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.pmedr.2022.101909

Impact of pneumonia and lung cancer on mortality of women with hypertension

Yuechun Shen, Zuojun Tian, Dongfeng Lu, Junyao Huang et al. • Scientific Reports (2016)

Abstract Essential hypertension is one of the most severe women’s health problems. Modern life brings more chances of pulmonary diseases to human. The purpose of the study is to investigate weather pneumonia and lung cancer are associated w...

DOAJ Open Access (DOAJ) DOI: 10.1038/s41598-016-0023-2

A hybrid nanomodulator enables metabolic microenvironment remodeling for potent immunotherapy against lung adenocarcinoma

Shuping Wang, Pengcheng Chen, Xiaozhen Jing, Jinglin Zou et al. • Materials & Design (2026)

STING agonist-based immunotherapy holds considerable promise for cancer treatment, yet its efficacy against immunologically “cold” tumors such as lung adenocarcinoma (LUAD) remains markedly limited. A major obstacle lies in the highly glyco...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.matdes.2026.117182

Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption

Charlotte Poon, Tim Wilsdon, Iqra Sarwar, Alexander Roediger et al. • Frontiers in Public Health (2023)

Strong evidence of lung cancer screening’s effectiveness in mortality reduction, as demonstrated in the National Lung Screening Trial (NLST) in the US and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON), has prompted count...

DOAJ Open Access (DOAJ) DOI: 10.3389/fpubh.2023.1264342

CBLL1 is highly expressed in non‐small cell lung cancer and promotes cell proliferation and invasion

Linping Hui, Siyang Zhang, Muli Wudu, Hongjiu Ren et al. • Thoracic Cancer (2019)

Background Studies have shown that E3 ubiquitin ligase CBLL1 plays multiple roles in development and tumorigenesis. CBLL1 is over‐expressed in colon cancer and associated with cancer cell proliferation. While, the overexpression of CBLL1 in...

DOAJ Open Access (DOAJ) DOI: 10.1111/1759-7714.13097

Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations

Pedro E.N.S. Vasconcelos, MS, Ikei S. Kobayashi, MD, PhD, Susumu S. Kobayashi, MD, PhD, Daniel B. Costa, MD, PhD • JTO Clinical and Research Reports (2021)

Introduction: EGFR exon 20 insertion mutations account for 10% of all EGFR mutations and are mostly insensitive to approved EGFR tyrosine kinase inhibitors (EGFR TKIs). Novel EGFR TKIs have been developed or repurposed for these mutants. A ...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jtocrr.2020.100105

Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability

Yuxiong Lu, Junichi Maruyama, Keiko Kuwata, Hiroyuki Fukuda et al. • Biochemistry and Biophysics Reports (2018)

Doublecortin-like kinase 1 (DCLK1) is a serine/threonine-kinase with two doublecortin (DCX) domains. DCLK1 is associated with microtubules via DCX domains and regulates microtubule polymerization. DCLK1 is known to be expressed in cancer st...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.bbrep.2018.10.014